Waters Corporation (WAT)
NYSE: WAT · Real-Time Price · USD
286.57
+3.25 (1.15%)
At close: Mar 13, 2026, 4:00 PM EDT
286.80
+0.23 (0.08%)
After-hours: Mar 13, 2026, 7:16 PM EDT
Revenue Breakdown
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
|---|
Waters Instrument Systems Revenue | 1.10B | 1.03B | | | | | | | | | | | | |
Waters Instrument Systems Revenue Growth | 6.71% | -6.87% | | | | | | | | | | | | |
Chemistry Consumables Revenue | 631.46M | 565.48M | | | | | | | | | | | | |
Chemistry Consumables Revenue Growth | 11.67% | 4.44% | | | | | | | | | | | | |
TA Instrument Systems Revenue | 243.82M | 246.20M | | | | | | | | | | | | |
TA Instrument Systems Revenue Growth | -0.97% | -2.64% | | | | | | | | | | | | |
Total Product Sales Revenue | 1.98B | 1.84B | | | | | | | | | | | | |
Total Product Sales Revenue Growth | 7.21% | -3.09% | | | | | | | | | | | | |
| 1.08B | 1.01B | | | | | | | | | | | | |
Waters Service Revenue Growth | 7.32% | 5.78% | | | | | | | | | | | | |
| 108.02M | 107.76M | | | | | | | | | | | | |
TA Service Revenue Growth | 0.24% | 5.71% | | | | | | | | | | | | |
Total Service Sales Revenue | 1.19B | 1.11B | | | | | | | | | | | | |
Total Service Sales Revenue Growth | 6.64% | 5.78% | | | | | | | | | | | | |
| 3.17B | 2.96B | | | | | | | | | | | | |
| 6.99% | 0.07% | | | | | | | | | | | | |
Revenue Breakdown 2
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 |
|---|
| 1.87B | 1.72B | | | | | | | | | | | | |
Pharmaceutical Revenue Growth | 8.99% | 1.30% | | | | | | | | | | | | |
| 961.15M | 908.49M | | | | | | | | | | | | |
Industrial Revenue Growth | 5.80% | -0.06% | | | | | | | | | | | | |
Academic and Governmental Revenue | 330.77M | 331.00M | | | | | | | | | | | | |
Academic and Governmental Revenue Growth | -0.07% | -5.57% | | | | | | | | | | | | |
| 3.17B | 2.96B | | | | | | | | | | | | |
| 6.99% | 0.07% | | | | | | | | | | | | |
Updated Feb 9, 2026. Data Source:
Fiscal.ai.